These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 26038456)

  • 1. T-cell responses in hepatitis B and C virus infection: similarities and differences.
    Schmidt J; Blum HE; Thimme R
    Emerg Microbes Infect; 2013 Mar; 2(3):e15. PubMed ID: 26038456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of the virus specific T-cell response in acute and chronic HBV and HCV infection].
    Panther E; Spangenberg HC; Neumann-Haefelin C; Rösler K; Blum HE; von Weizsäcker F; Thimme R
    Z Gastroenterol; 2004 Jan; 42(1):39-46. PubMed ID: 14997402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
    Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
    Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Kupffer cells in hepatitis B and hepatitis C virus infections.
    Boltjes A; Movita D; Boonstra A; Woltman AM
    J Hepatol; 2014 Sep; 61(3):660-71. PubMed ID: 24798624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Success and failure of virus-specific T cell responses in hepatitis C virus infection.
    Neumann-Haefelin C; Thimme R
    Dig Dis; 2011; 29(4):416-22. PubMed ID: 21894013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined blockade of programmed death-1 and activation of CD137 increase responses of human liver T cells against HBV, but not HCV.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Ravanetti L; Urbani S; Giuberti T; Cavalli A; Vandelli C; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2012 Dec; 143(6):1576-1585.e4. PubMed ID: 22929808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus: from diagnosis to treatment.
    Dény P; Zoulim F
    Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes determining the course of virus persistence in the liver: lessons from murine infection with lymphocytic choriomeningitis virus.
    Lang PA; Recher M; Häussinger D; Lang KS
    Cell Physiol Biochem; 2010; 26(3):263-72. PubMed ID: 20798510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection.
    Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V
    J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma and infections with multiple hepatitis viruses.
    Brunetto MR; Oliveri F; Colombatto P; Bonino F
    Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune responses in hepatitis C virus infection.
    Spengler U; Lechmann M; Irrgang B; Dumoulin FL; Sauerbruch T
    J Hepatol; 1996; 24(2 Suppl):20-5. PubMed ID: 8836885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus immunopathogenesis.
    Chisari FV; Ferrari C
    Annu Rev Immunol; 1995; 13():29-60. PubMed ID: 7612225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
    Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
    J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of chronic schistosomiasis and HBV/HCV co-infection on the liver: current perspectives.
    Omar HH
    Hepat Med; 2019; 11():131-136. PubMed ID: 31565002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.